Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Horm Behav. 2018 Oct 9;111:78–86. doi: 10.1016/j.yhbeh.2018.09.003

Light as a modulator of emotion and cognition: lessons learned from studying a diurnal rodent

Lily Yan 1,*, Joseph S Lonstein 1, Antonio A Nunez 1
PMCID: PMC6456444  NIHMSID: NIHMS1509350  PMID: 30244030

Abstract

Light profoundly affects the behavior and physiology of almost all animals, including humans. One such effect in humans is that the level of illumination during the day positively contributes to affective well-being and cognitive function. However, the neural mechanisms underlying the effects of daytime light intensity on affect and cognition are poorly understood. One barrier for progress in this area is that almost all laboratory animal models studied are nocturnal. There are substantial differences in how light affects nocturnal and diurnal species, e.g., light induces sleep in nocturnal mammals and wakefulness in diurnal ones, like humans. Therefore, the mechanisms through which light modulates affect and cognition must differ between the chronotypes. To further understand the neural pathways mediating how ambient light modulates affect and cognition, our recent work has developed a diurnal rodent model, the Nile grass rat (Arvichantis niloticus), by chronically manipulating daytime light intensity in grass rats housed under the same 12:12hr light/dark cycle. This simulates lighting conditions during summer-like bright sunny days vs. winter-like dim cloudy days. Our work has revealed that chronic dim daylight intensity results in higher depression- and anxiety-like behaviors, as well as impaired spatial learning and memory. Furthermore, we have found that hypothalamic orexin is a mediator of these effects. A better understanding of how changes in daytime light intensity impinge upon the neural substrates involved in affect and cognition will lead to novel preventive and therapeutic strategies for Seasonal Affective Disorder, as well as non-seasonal emotional or cognitive impairments associated with light deficiency.

Keywords: ambient light, animal model, anxiety, depression, diurnal, nocturnal, spatial learning, spatial memory, nocturnal, seasonal affective disorder


Light is a highly salient environmental factor influencing the brain and behavior beyond its role in visual perception. In mammalian species including humans, the so called non-image forming effects of light include entraining circadian rhythms, mediating pupillary reflexes, regulating peripheral physiological events, promoting alertness or arousal, and modulating affect and cognition (Foster and Hankins, 2002; Fu et al., 2005). The daily light/dark cycle is the most reliable and predictable cue to entrain the circadian system (Daan and Aschoff, 2001). This system coordinates daily rhythms in our bodily functions to ensure that the activities among the various tissues and organs are synchronized with each other and with the day/night or light/dark cycles (Hastings et al., 2003).

While the illuminance necessary for entrainment varies among species, for humans, light as low as 120 lux is sufficient (Zeitzer et al., 2000). Light in our natural environment is much brighter, though, with examples being >1,000 lux in a typical retail store or ~100,000 lux outside on a bright sunny midday (Turner et al., 2010). Such different levels of illumination during the day have been found to influence human behavior and physiology. Compared to low daytime light intensity, bright illumination during the day increases arousal and enhances attention (Altimus et al., 2008; Ruger et al., 2006), activates digestive activity (Lee et al., 2001; Sone et al., 2003), suppresses plasma cortisol levels (Jung et al., 2010), and increases the nocturnal rise of melatonin (Park and Tokura, 1999). Furthermore, for patients that recently underwent spinal surgery, more sunlight in their hospital rooms decreased their pain and analgesic use (Walch et al., 2005), and heart attack patients in sunny hospital rooms have relatively shorter hospital stays and higher survival rates (Beauchemin and Hays, 1998). As will be discussed below as the focus of this review, brighter daytime illumination has also been found to have positive effects on affective well-being and cognitive function in humans, while insufficient light exposure during the day can lead to affective disorders and cognitive impairments.

Daylight modulates affect and cognition in humans

The impact of light on our affective state is best exemplified by seasonal affective disorder (SAD) and the effectiveness of bright light therapy in preventing, or at least alleviating, many of its symptoms (Lam et al., 2006; Nussbaumer et al., 2015; Rosenthal et al., 1984; Terman and Terman, 2005). SAD is a major depressive disorder occurring with a seasonal pattern that affects millions of Americans every year (Howland, 2009). Affected individuals experience regularly recurring episodes of depression and anxiety each fall and winter, followed by spontaneous remission in spring and summer (Rosenthal et al., 1984). Bright light therapy is effective in alleviating the symptoms of SAD, suggesting that the cause of this disorder lies in the seasonal fluctuation in lighting condition. In addition to SAD, bright light therapy has been successfully used to treat non-seasonal depression, suggesting modulatory effects of light on mood regardless of season (Even et al., 2008; Golden et al., 2005; Tuunainen et al., 2004). A recent study showed that for hospitalized depression patients, those staying in southeast-facing rooms recovered much faster compared those who stayed in northwest-facing rooms (29.2 ± 26.8 versus 58.8 ± 42.0 days) (Gbyl et al., 2016). The only factor that could account for the speedy recovery in southeast-facing patients is that their rooms were much brighter compared to those in the other side of the building, and the difference was up to 20-fold at any given time of the year. A group of retinal ganglion cells containing the photoreceptor molecule melanopsin play a critical role in detecting light intensity and mediating the non-image forming effects of light (Hattar et al., 2003). Homozygosity for a missense single-nucleotide polymorphisms in the melanopsin gene increases the risk of SAD by over 500%, suggesting deficits in non-visual pathways from the retina as risk factors that may predispose some individuals to the disorder (Roecklein et al., 2009). Retinal disease that leads to visual impairment is also consistently associated with depression and anxiety (Augustin et al., 2007; Ribeiro et al., 2015). Although in the latter cases the high prevalence of depression and anxiety could very reasonably be secondary to the visual impairments, the direct impact of the diminished non-image forming photic stimulation to the brain should not be underestimated.

In addition to depression and anxiety, SAD patients also experience cognitive impairments including slower cognitive processing as well as impaired working and spatial memory (O’Brien et al., 1993; Sullivan and Payne, 2007). Seasonal effects on cognitive function have also been documented in non-clinical populations. A recent fMRI study revealed seasonal fluctuation in brain activity during cognitive tasks, such that the brain responses to a sustained attention task were highest in summer and lowest in winter, while the responses to working memory were highest in the fall and lowest in spring (Meyer et al., 2016). The impact of light on cognitive function has also been documented in human populations independent of season. As examples, brighter illumination in the classroom enhances math and reading performance of elementary school students (Barkmann et al., 2012; Heschong, 2002; Heschong et al., 2002; Mott et al., 2012), bright office lighting increases performance of adults in the workplace (Baron et al., 1992; Mills et al., 2007; Viola et al., 2008), and bright light therapy improves cognition in mild/early-stage dementia in some studies (Forbes et al., 2009; Riemersma-van der Lek et al., 2008; Yamadera et al., 2000).

Studying a diurnal animal is essential for elucidating the mechanisms responsible for daylight’s modulation of human affect and cognition

Evidence from the literature on both clinical and non-clinical populations summarized above has firmly established that environmental lighting condition is an important modulator of mood and cognition in humans. However, how bright daylight produces its positive effects on affective and cognitive outcomes is poorly understood, and research in this area has been greatly hindered by a lack of an appropriate animal to study such questions. In contrast to humans that are diurnal and, thus, most active during the day, the most commonly used laboratory rodents such as mice or rats are nocturnal and active at night. Although light entrains or resets circadian rhythms in a manner that is very similar or even the same between nocturnal and diurnal mammals including humans, the circadian-independent direct effects of light on the brain and behavior are very different (Challet, 2007; Minors et al., 1991; Smale et al., 2003; Yan et al., 2018). Indeed, light increases physical activity and promotes arousal in diurnal mammals, while light inhibits activity and promotes sleep in nocturnal ones (Redlin, 2001). Therefore, studying a diurnal animal is absolutely essential to fully understand the impact of ambient light on the human brain, behavior, and physiology through light’s circadian-dependent and circadianindependent mechanisms (Fig. 1).

Figure 1.

Figure 1.

Hypothetical model showing how light modulates af-fect (as well as cognition) through both circadian and non-circadian systems. Light resets the principal circadian clock located in the suprachiasmatic nucleus (SCN) of both diurnal and nocturnal mammals. Light activation of the orexinergic system (OX) is unique to diurnal mammals and, thus, can only be studied in a diurnal model such as Nile grass rats. Both systems regulate functions of the monoaminergic system, subcortical regions of the limbic system including the hippo-campus, and the prefrontal cortex (PFC) – all of which are involved in regulating affect and cognition.

A small number of diurnal rodent species are available to study in laboratory settings and include degus (Octodon degus), Mongolian gerbils (Meriones unguiculatus) and Nile grass rats (Arvichantis niloticus). Of these diurnal rodents, Nile grass rats have the highest diurnality index at 87%, i.e., the percentage of daily activity occurring during the daytime (Refinetti, 2008). Work from our group discussed below utilizing male Nile grass rats (and very recently also involving females) has established that daytime lighting conditions influence their emotional and cognitive behaviors in a way similar to that seen in humans, such that insufficient light exposure during the day leads to increased depression- and anxiety-like behaviors, as well as impaired spatial learning and memory.

Daytime light deficiency impairs affective behaviors and cognition in grass rats in ways analogous to those seen in humans

Depression-like behaviors have been consistently observed by our group and others in diurnal grass rats housed in winter-like lighting conditions involving short day-length of either 5:19 or 8:16 hours light/dark (LD) cycle (Ashkenazy-Frolinger et al., 2009; Leach et al., 2013 -b), or involving low light intensity even if when maintained on a 12:12 hours LD cycle (Leach et al., 2013 -a). These clearly demonstrate that not only does winter-like short day length, but also winter-like low daylight intensity, contributes to the behavioral deficits. The reliable depressionlike behavior under winter-like lighting conditions also strongly supports the face validity of the diurnal grass rat as a model of SAD. Following these initial findings, we focused our investigation using the low light intensity paradigm instead of the short photoperiod due to the fact that it is much more relevant to the seasonal changes in light intensity experienced by humans. Importantly, because most humans around the globe use artificial lights, the duration of daily light exposure we experience across seasons does not fluctuate nearly as much as the quality/intensity of light. In a study monitoring light exposure in a group of subjects at the 45° N latitude (Quebec, Canada) where the natural day-length fluctuates between 8 to 16 hours across the year, the total duration of light exposure experienced by the subjects was not significantly different between winter and summer (14.6 ± 1.2 vs. 14.9 ± 1.5 hours). However, the duration of light above 1000 lux was greatly reduced in winter compared to summer (2.6 ± 1.2 vs. 0.4 ± 0.3 hours) (Hebert et al., 1998). Therefore, the change in daylight intensity over the seasons is a more salient factor than daylight duration for driving seasonality in modern humans.

To assess the effects of daytime light intensity on affective and cognitive responses, we housed diurnal grass rats under a 12:12 hours LD condition with either bright (1000 lux, brLD) or dim light (50 lux, dimLD) during the day, thus resembling the lighting conditions that many of us experience in summer or winter, respectively. It should be noted that the light exposure is voluntary because the animals can always avoid the light by hiding in a PVC tube provided as enrichment in their home cages. Even so, we have often observed that the animals in the brLD condition stand on top of the PVC tube to be closer to the light source, suggesting that the light at 1000 lux (which is higher than the standard for most laboratory rodent animal facilities) is not aversive but rather desirable for the grass rats. Following 4 weeks in each lighting condition, the animals underwent behavioral testing. Consistent to what has been observed in humans suffering with SAD, compared to the control group housed in the summer-like brLD condition, grass rats housed in winter-like dimLD condition showed increased depression- and anxiety-like behaviors. Depression-like behaviors were assessed in the classic forced swim test (FST) and sweet solution preference (SSP) test (Leach et al., 2013 -a). In the FST, the dimLD animals showed longer immobility and less climbing/escaping, indicating more behavioral despair (Fig. 2). In a SSP test that permits free ingestion of 1% saccharin and tap water, the SSP of dimLD animals was significantly lower than that of brLD animals, indicating anhedonia. Anxiety-like behaviors were assessed in open field and marble burying tests (Ikeno et al., 2016). In the open field test, animals in the dimLD group had fewer center entries and spent less time at the center of the testing arena (Fig. 3). In the marble burying test, the dimLD group buried twice many marbles, compared to the brLD group. The behavioral responses in both tests reveal anxiety-like phenotype of animals housed in dimLD.

Figure 2.

Figure 2.

Daytime dim light housing leads to depression-like behavioral responses. A. Diagrams depicting the bright light:dark (brLD) and dim light:dark (dimLD) conditions used to study behavior in Nile grass rats. B. Bar graphs show the duration of immobility, escaping, and swimming by grass rats during forced swim tests (FST), indicating behavioral despair in the animals housed in dimLD. C. The changes in preference for saccharine solution by grass rats in sweet solution preference (SSP) tests. Animals in brLD showed a steady increase in their SSP, while dimLD group did not show an increase of SSP over 3 days of exposure, indicating anhedonia. Results are displayed as mean ± SEM. * indicates p < 0.05. (B and C are modified from Fig. 1 in (Leach et al., 2013 -a).

Figure 3.

Figure 3.

Daytime dim light housing leads to increased anxiety-like behavior. (A, B) Representative tracks in an open field by grass rats housed in the brLD (A) and dimLD (B) conditions. The center/perimeter boundaries are shown in grey lines. (C) Total number of center entries. (D) Total time spent in the center. Results are shown as mean ± SEM. *p < 0.01 (adapted from Figure 1 in Tomoko et al., 2013 with permission).

We also examined the effects of daytime light intensity on spatial learning and memory using the hippocampal dependent Morris water maze (MWM) task (Soler et al., 2018). Lighting condition affected the latency for the animals to locate the platform across the training days (2 trials/day for 5 days), with the effect being significant only for trial 1 (24 hours interval from the previous trial), but not trial 2 (30 seconds after trail 1) of each day, indicating that retention of the memory for the platform location was impaired after a 24 hours interval, but that working memory was intact in the dimLD animals (Fig. 4). During the 60-second probe test administered 24 hours after the last training day, the dimLD animals spent ~15 seconds of the testing period in the goal quadrant, which is at chance level, indicating impairments of spatial memory (Fig. 4). It is noteworthy that there was no difference in thigmotaxis (time spent swimming next to the wall and a measure of anxiety) between the two groups during the probe test. This finding seems inconsistent with the anxiety-like phenotype of dimLD animals we observed in previous studies, which included increased thigmotaxis by dimLD animals during open field and forced swim tests (Deats et al., 2014; Ikeno et al., 2016). The different behavioral response could be due to the fact that 1) the pool for the MWM task is much larger than the open field arena or the pool used for the forced swim testing, and 2) the MWM task is goal-oriented and the animals are motivated to find the platform hidden near the center of the pool, thus conditions are biased against the display of thigmotaxic behavior.

Figure 4.

Figure 4.

Impaired MWM performance of grass rats housed in dimLD compared to those in brLD condition. (A) Latency of animals to locate the platform during trial 1 (24-hour delay) over the five training days. Grass rats housed in brLD were able to locate the platform significantly faster in the than those housed in dimLD. (B) Latency of animals to locate the platform during trial 2 (30-second delay); there were no significant differences between the two groups. (C) Representative track plots of a grass rat in each lighting condition during the probe trial (with goal quadrant highlighted). (D) Grass rats housed in brLD nearly spent twice as much time searching for the platform in the goal quadrant in the probe test when compared to grass rats in the dimLD group. *, p < 0.05 (adapted from Figure 1 in Soler et al., 2018 with permission).

The circadian system is not responsible for the behavioral impairments seen in grass rats under winter-like dimLD conditions

The current prevailing theory on the etiology of SAD continues to be the phase-shifting hypothesis, which proposes that the episodes of depression are caused by misalignments between one’s circadian rhythm and habitual sleep time (Lewy et al., 2007). The clinical practice of using light therapy is based on this theory (Lewy, 2009; Terman and Terman, 2005), which is derived from the fact that light is undoubtedly the most salient cue for resetting circadian rhythms (Daan and Aschoff, 2001). However, the light intensity required for effective light therapy in humans (>5000 lux (Terman et al., 1996; Terman and Terman, 2005)) is known to greatly exceed that needed to shift our circadian rhythms (120 lux, (Zeitzer et al., 2000)). Thus, the role that the circadian system plays in SAD is not completely clear.

To determine if circadian rhythm disruption underlies the behavioral impairments seen in our grass rats housed under dimLD conditions, we compared their daily rhythms in locomotor activity to animals in the brLD condition (Fig. 5A; (Leach et al., 2013 -a)). There were no significant differences between the two conditions in terms of the animals’ total daily activity, day/night activity ratio, and entrainment phase angle (i.e., the activity onset and offset time in reference to lights on and off, respectively). The only significant difference found was in the entrainment stability measured by the activity offset, with greater variability in the timing of the end point of daily activity for animals housed in dimLD compared to those in brLD. However, there was no difference when the entrainment stability was assessed based on activity onset time. Therefore, the analysis of locomotor activity revealed no major differences in daily rhythms that could have contributed to the behavioral impairments in the dimLD group (Leach et al., 2013 -a).

Figure 5.

Figure 5.

Daily rhythms in locomotor activity and expression of the clock protein PER2 in the SCN are comparable between grass rats housed in brLD or dimLD conditions. (A) Actograms depict representative daily activity of a grass rat housed in each condition over two weeks. Daily activity is double-blotted so each horizontal line shows activity over two days. Each vertical bar shows the amount of activity over a 10-minute bin. In both conditions, the majority of activity occurred during daytime. (B) PER2 immunoreactivity in the SCN. Scale bar, 100 μm (adapted from Figure 3 in (Leach et al., 2013 -a).

The grass rat model of SAD also allowed us to directly examine the functioning of circadian oscillators, including the principal brain clock within the suprachiasmatic nucleus (SCN). We examined the expression of the protein product of the canonic clock gene PER2 in the SCN across a daily cycle in grass rats housed in brLD or dimLD and found no significant differences between the groups (Fig. 5B, Ikeno and Yan, unpublished results).

It is well established that circadian rhythm disruption is a causal factor for mood disorders and cognitive impairments (Evans and Davidson, 2013; McClung, 2011; Wright et al., 2012). However, the rather subtle differences in circadian rhythms between the brLD and dimLD grass rats, and the much higher intensity required for the antidepressant effects of light therapy than that for circadian entrainment in humans (i.e. 5000 vs. 120 lux), collectively suggest that there are mechanisms in addition to - and more importantly independent of - circadian disruption that contribute to the behavioral deficits caused by daytime light deficiency.

Does the orexin system underlie the behavioral deficits caused by daytime light deficiency?

Orexin, also known as hypocretin, has two isoforms (orexin A and orexin B) that have been implicated in many important physiological functions including wakefulness, energy homeostasis, reward, emotion, and cognition (Gerashchenko and Shiromani, 2004; Tsujino and Sakurai, 2009). The sequence and structure of orexin peptides are well conserved across mammals including mice, rats, dogs, pigs and humans (Sakurai, 2005). Mood and anxiety disorders are prevalent in narcoleptic patients that have diminished central orexin levels (Fortuyn et al., 2010; Ohayon, 2013). Lower orexin levels in cerebrospinal fluid have also been reported in patients suffering from major depressive disorder or comorbid depression and anxiety ((Brundin et al., 2007; Brundin et al., 2009; Brundin et al., 2007; Johnson et al., 2010; Rotter et al., 2011) also see (Schmidt et al., 2011)). In animal models of depression, reduced brain orexin peptide content and a reduced number or size of orexin neurons have been reported (Allard et al., 2004; Nocjar et al., 2012). There is also evidence for the involvement of the orexinergic system in cognition. Dysfunction in the orexin system has been implicated in dementia and in cognitive decline in post-stroke patients (Song et al., 2015; Wennstrom et al., 2012). In nocturnal rodents, orexin has been shown to modulate hippocampal-dependent spatial learning (Sil’kis, 2013). Orexin A also reverses the impaired spatial learning and memory in a mouse epilepsy model (Zhao et al., 2014), and improves retention in avoidance learning (Jaeger et al., 2002). There are two types of G-protein-coupled receptors that bind to orexin. Type 1 receptor (OX1R) shows higher affinity for orexin A, while type 2 receptor (OX2R) has similar affinity to both orexin A and B (Sakurai et al., 1998). Administering a selective OX1R antagonist into CA1 impairs learning in the MWM task (Akbari et al., 2006, 2007), suggesting that OX1R-mediated signaling in CA1 is involved in spatial learning.

Most orexin-containing neurons in the brain are localized in the lateral hypothalamus of humans (Aziz et al., 2008; Thannickal et al., 2009), as well as in diurnal and nocturnal rodents (Donlin et al., 2014; Nixon and Smale, 2007). In both laboratory rats and grass rats, there are direct retinal projections to the lateral hypothalamus where most orexinergic cells are found (Gaillard et al., 2013; Johnson et al., 1988; Leak and Moore, 1997). These hypothalamic orexin neurons also receive retinal input indirectly through the suprachiasmatic nucleus in both species (Deurveilher and Semba, 2005; Schwartz et al., 2011). In diurnal grass rats, we have found that acute light exposure activates orexin neurons as revealed by increased Fos expression, indicating that these cells are light responsive (Adidharma et al., 2012). We then assessed the effects of daytime illumination level on the orexin neurons. Compared to grass rats housed for 4 weeks in the bright daylight conditions, the dimDL animals had fewer orexin-ir cells in the hypothalamus and lower orexin-ir fiber density in the midbrain dorsal raphe nucleus (Deats et al., 2014), suggesting decreased central orexin levels and attenuated orexinergic output (Fig. 6). Furthermore, administering a selective OX1R antagonist to animals in the brLD condition increased their depression- and anxiety-like behaviors (Deats et al., 2014), suggesting that intact orexin-OX1R pathways are critical for affective regulation in grass rats.

Figure 6.

Figure 6.

Daytime dim light housing leads to attenuated orexin immunoreactivity in the hypothalamus (upper panel) and the dorsal raphe nucleus (lower panel). aq, cerebral aqueduct; mlf, medial longitudinal fasciculus. Scale bars = 250 μm (modified from Figures 1 and 2 in Deats et al., 2014 with permission).

Critically important for modulating depression, anxiety, learning and memory is that orexinergic cells project heavily to the prefrontal cortex, monoaminergic systems, and hippocampus in both nocturnal laboratory rats and diurnal grass rats (Nixon and Smale, 2007; Peyron et al., 1998). Using diurnal grass rats, we have investigated the effects of daytime light intensity on some targets of the hypothalamic orexin cells, to explore the potential downstream pathways from light via orexin neurons in mediating the effects of daytime illumination on affect and cognition.

The dorsal raphe nucleus (DRN):

Orexin cells project heavily to central monoaminergic systems including the serotonin (5-HT)-rich DRN (Nixon and Smale, 2007; Peyron et al., 1998), where it induces excitatory responses in 5-HTergic cells (Soffin et al., 2004) and stimulates the release of 5-HT (Tao et al., 2006). Dysfunction in the central 5-HT system has long been implicated in the pathophysiology of SAD. SAD patients in clinical remission will relapse following depletion of the 5-HT precursor, tryptophan (Kulikov and Popova, 2015; Lam et al., 2001; Levitan, 2007; Neumeister et al., 2001). There are also seasonal variations in the 5-HT system. In humans, hypothalamic 5-HT levels (Carlsson et al., 1980), 5-HT turnover as measured by its metabolite levels in cerebrospinal fluid (Brewerton et al., 1988; Luykx et al., 2013) and availability of 5-HT1A receptors in a variety of subcortical sites (Matheson et al., 2015) are lowest in winter, while 5-HT transporter binding potential in cortical and subcortical sites is highest in fall and winter (Praschak-Rieder et al., 2008). It has also been shown that bright sunlight rapidly increases 5-HT production, which is correlated with the duration and intensity of light exposure (Lambert et al., 2002). In diurnal grass rats, we found that dimLD animals had fewer 5-HT-ir cells in the middle and caudal DRN, and lower 5-HT-ir fiber density in medial cingulate cortex, when compared to brLD animals (Leach et al., 2013 -a). This suppression of midbrain and frontocortical 5-HT in dimLD animals is consistent with our finding that bright light increases immediate-early gene activity in the grass rat DRN (Adidharma et al., 2012). Although a direct retinal projection to the dorsal raphe has been reported in many species including laboratory rats, degus, gerbils, tree shrews, and tufted capuchin monkeys (Fite and Janusonis, 2001; Fite et al., 1999; Frazao et al., 2008; Ren et al., 2013; Reuss and Fuchs, 2000; Shen and Semba, 1994), no direct retinal innervation of the DRN was found in laboratory mice, ground squirrels, or grass rats (Gaillard et al., 2013; Hattar et al., 2006; Major et al., 2003; Morin and Studholme, 2014). Consistent with the anatomy, we have found that systemic injection of the selective OX1R antagonist, SB-334867, attenuates light-activated Fos expression in the DRN by almost 50%, suggesting that the light-induced activation of the DRN in grass rats is indirectly mediated by the OXA-OX1R pathway (Adidharma et al., 2012).

Hippocampus:

The hippocampus has long been a focus for studies on learning and memory (Jarrard, 1993; Squire, 1992), and has also been implicated in depression (Campbell and Macqueen, 2004; MacQueen and Frodl, 2011) and anxiety (Bannerman et al., 2004; Shin and Liberzon, 2010). Orexinergic cells project directly to the hippocampus in both nocturnal laboratory rats and diurnal grass rats (Nixon and Smale, 2007; Peyron et al., 1998). Orexin receptors are expressed in the hippocampus of both rodents (Ikeno and Yan, 2018; Marcus et al., 2001; Trivedi et al., 1998). In grass rats, we examined their hippocampus focusing on the expression of the neurotrophic factor, BDNF, and on the CA1 dendritic spine density (Soler et al., 2018). We found a significant reduction in the number of hippocampal BDNF-ir cells in the dimLD condition, and the reduction was specific to the CA1 subregion. This finding was confirmed by measurements of BDNF mRNA and protein using qPCR and Western blot, respectively. There was also a reduction in the CA1 apical dendritic spine density in the dimLD group compared to brLD group. Interestingly, when a group of dimLD animals were transferred into the brLD condition for 4 weeks, both the BDNF expression and CA1 dendritic spine density recovered. Hippocampal BDNF and spine density have been implicated in spatial learning and memory (Bekinschtein et al., 2008; Matsuzaki et al., 2004; Tsien et al., 1996) as well as in depression (Castren et al., 2007; Duman, 2002). Our findings revealed that daytime illumination modulates structural plasticity in the hippocampus, which likely underlies the differential depression-like behaviors and spatial learning of animals housed in dim and bright days.

HPA axis:

Dysregulation of HPA axis has often been implicated in affective disorders (Belvederi Murri et al., 2016; Pariante and Lightman, 2008; Zorn et al., 2017). Although we have found no differences between grass rats housed in brLD and dimLD conditions in their basal plasma corticosterone (CORT) at daytime or nighttime, nor in their adrenal gland weights, the dimLD group had relatively higher plasma CORT following an acute mild stressor (marbleburying test (Ikeno et al., 2016). The higher CORT levels in the dimLD group were accompanied by higher Fos immunoreactivity in the CA3 and dentate gyrus of the hippocampus, suggesting abnormal hippocampal regulation of the HPA axis in the dimLD animals. In fact, we found that dimLD grass rats had higher hippocampal expression of the mRNAs for mineralocorticoid receptors (MR) at ZT2 and ZT14, and glucocorticoid receptors (GR) at ZT2, compared to that found in the brLD group. No such differences in MR or GR mRNAs were found in the PVN (Ikeno et al., 2016). While limiting light exposure via short photoperiod has previously been seen to increase hippocampal MR and GR expression in nocturnal rodents (Lance et al., 1998; Pyter et al., 2007), the upregulation in the hippocampus of the dimLD grass rats was unexpected. Higher hippocampal MR and GR expression would be expected to result in less initial CORT release and stronger negative feedback on the HPA axis in response to a stressor, rather than the higher plasma CORT we observed in the dimLD group. However, we measured CORT only at one time point (1 hour) after the animals encountered the mild stressor. A complete time course sampling plasma CORT from before the stress induction through complete recovery will be necessary to evaluate how changes in MR and GR mRNA are related to the HPA axis regulation in brDL and dimDL grass rats. Nonetheless, our results collectively suggest that the dimLD condition is associated with enhanced stress responding at multiple levels including in the animals’ behavior, hormone secretion, and hippocampal gene expression.

Conclusions and future perspectives

Using the diurnal Nile grass rat, we have found that daytime light intensity level has significant impacts on affective behaviors and spatial learning and memory. Brighter daytime illumination reduces depression- and anxiety-like behaviors and enhances spatial memory, while relatively dim light during the daytime leads to increased depression- and anxiety-like behaviors and impaired spatial memory. These behavioral responses observed in grass rats mirror what have been documented in humans, with bright light associated with better mood and better cognitive performance. Thus, the grass rat provides a unique opportunity to reveal the neural mechanisms through which daytime light intensity modulates emotion and cognitions in humans. Current available data suggest that the hypothalamic orexin system is an important mediator of these effects, by responding to changes in the level of daytime illumination and conveying such information to other brain regions involved in affective behaviors and spatial memory (Fig. 1). Light-induced activation of orexin neurons is unique for diurnal species (Adidharma et al., 2012) because in nocturnal rodents, orexin neurons are not activated by light (Mendoza et al., 2010) and instead activated by darkness (Marston et al., 2008), which represents an arousal cue for these and other nocturnal animals. Interestingly, there are a handful of chronotype differences in the distribution of orexin receptors, especially OX1R, in brain regions implicated in sleep/wakefulness, affect, and cognition (Ikeno and Yan, 2018; Marcus et al., 2001; Trivedi et al., 1998). For instance, in the caudate putamen and ventral tuberomammillary nucleus, OX1R expression was detected in diurnal grass rats but not in nocturnal laboratory mice or rats; while in the medial division of the posteromedial bed nucleus of the stria terminalis OX1R was detected in mice but not in grass rats. These differences may eventually be found to underlie different roles for the OX1R in processing light in diurnal and nocturnal species.

Although our work has focused on the effects of differential light intensity, other parameters of ambient daylight including the duration of light exposure or the spectrum of light, are known to play a role in affective and cognitive behaviors in some diurnal and nocturnal rodents (Einat et al., 2006; Itzhacki et al., 2018; Leach et al., 2013; Prendergast and Kay, 2008; Prendergast and Nelson, 2005; Pyter et al., 2005; Steinman et al., 2011), and these parameters will be explored in our future studies of grass rats. It should also be noted that the work discussed here is based on results obtained from male grass rats. We are currently investing the effects of daytime light intensity in female grass rats, and the initial findings have suggested some intriguing sex differences. Indeed, following the same housing condition in dimLD, the memory deficits in female grass rats are more severe compared to that found in males (Yan et al., 2017), and the effects of daytime light intensity on the levels orexin receptors also appear to be sex-specific in some brain regions (Tang et al., 2018).

In sum, the work summarized in this review is a first step toward a better understanding of how light, via orexin, modulates affect and cognition in diurnal mammals. Such knowledge is essential for designing lighting environments that promote optimal affective and cognitive functioning, and for identifying risk factors and pharmacological targets for affective disorders and cognitive impairments in humans.

Highlights.

  • Light profoundly affects behavior and physiology of all animals including humans.

  • In humans, bright light promotes affective well-being and cognitive function.

  • A diurnal model is critical for studying how light affects our mood and cognition.

  • Studies using diurnal grass rats shed light on how light modulates brain functions.

Acknowledgements:

Research from the authors discussed in this review was supported by grants R03MH093760 to LY, R01MH111276 to LY and JSL, R21NS098173 to LY and AAN. We thank Dr. Stephen R. Thomas for his help with creating some of the figures.

Footnotes

Declarations of interest: none

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Adidharma W, Leach G, Yan L, 2012. Orexinergic signaling mediates light-induced neuronal activation in the dorsal raphe nucleus. Neuroscience 220, 201–207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Akbari E, Naghdi N, Motamedi F, 2006. Functional inactivation of orexin 1 receptors in CA1 region impairs acquisition, consolidation and retrieval in Morris water maze task. Behav Brain Res 173, 47–52. [DOI] [PubMed] [Google Scholar]
  3. Akbari E, Naghdi N, Motamedi F, 2007. The selective orexin 1 receptor antagonist SB334867-A impairs acquisition and consolidation but not retrieval of spatial memory in Morris water maze. Peptides 28, 650–656. [DOI] [PubMed] [Google Scholar]
  4. Allard JS, Tizabi Y, Shaffery JP, Trouth CO, Manaye K, 2004. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression. Neuropeptides 38, 311–315. [DOI] [PubMed] [Google Scholar]
  5. Altimus CM, Guler AD, Villa KL, McNeill DS, Legates TA, Hattar S, 2008. Rodscones and melanopsin detect light and dark to modulate sleep independent of image formation. Proc Natl Acad Sci U S A 105, 19998–20003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ashkenazy-Frolinger T, Kronfeld-Schor N, Juetten J, Einat H, 2009. It is darkness and not light: Depression-like behaviors of diurnal unstriped Nile grass rats maintained under a short photoperiod schedule. J Neurosci Methods 186, 165–170. [DOI] [PubMed] [Google Scholar]
  7. Augustin A, Sahel JA, Bandello F, Dardennes R, Maurel F, Negrini C, Hieke K, Berdeaux G, 2007. Anxiety and depression prevalence rates in age-related macular degeneration. Invest Ophthalmol Vis Sci 48, 1498–1503. [DOI] [PubMed] [Google Scholar]
  8. Aziz A, Fronczek R, Maat-Schieman M, Unmehopa U, Roelandse F, Overeem S, van Duinen S, Lammers GJ, Swaab D, Roos R, 2008. Hypocretin and melanin-concentrating hormone in patients with Huntington disease. Brain Pathol 18, 474–483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bannerman DM, Rawlins JN, McHugh SB, Deacon RM, Yee BK, Bast T, Zhang WN, Pothuizen HH, Feldon J, 2004. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 28, 273–283. [DOI] [PubMed] [Google Scholar]
  10. Barkmann C, Wessolowski N, Schulte-Markwort M, 2012. Applicability and efficacy of variable light in schools. Physiol Behav 105, 621–627. [DOI] [PubMed] [Google Scholar]
  11. Baron R, Rea M, Daniels S, 1992. Effects of indoor lighting (illuminance and spectral distribution) on the performance of cognitive tasks and interpersonal behaviors: the potential mediating role of positive affect. Motivation and Emotion 16, 1–33. [Google Scholar]
  12. Beauchemin KM, Hays P, 1998. Dying in the dark: sunshine, gender and outcomes in myocardial infarction. J R Soc Med 91, 352–354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, Izquierdo I, Medina JH, 2008. BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci U S A 105, 2711–2716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Belvederi Murri M, Prestia D, Mondelli V, Pariante C, Patti S, Olivieri B, Arzani C, Masotti M, Respino M, Antonioli M, Vassallo L, Serafini G, Perna G, Pompili M, Amore M, 2016. The HPA axis in bipolar disorder: Systematic review and meta-analysis. Psychoneuroendocrinology 63, 327–342. [DOI] [PubMed] [Google Scholar]
  15. Brewerton TD, Berrettini WH, Nurnberger JI Jr., Linnoila M, 1988. Analysis of seasonal fluctuations of CSF monoamine metabolites and neuropeptides in normal controls: findings with 5HIAA and HVA. Psychiatry Res 23, 257–265. [DOI] [PubMed] [Google Scholar]
  16. Brundin L, Bjorkqvist M, Petersen A, Traskman-Bendz L, 2007. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur Neuropsychopharmacol 17, 573–579. [DOI] [PubMed] [Google Scholar]
  17. Brundin L, Bjorkqvist M, Traskman-Bendz L, Petersen A, 2009. Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt. J Affect Disord 113, 179–182. [DOI] [PubMed] [Google Scholar]
  18. Brundin L, Petersen A, Bjorkqvist M, Traskman-Bendz L, 2007. Orexin and psychiatric symptoms in suicide attempters. J Affect Disord 100, 259–263. [DOI] [PubMed] [Google Scholar]
  19. Campbell S, Macqueen G, 2004. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 29, 417–426. [PMC free article] [PubMed] [Google Scholar]
  20. Carlsson A, Svennerholm L, Winblad B, 1980. Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr Scand Suppl 280, 75–85. [PubMed] [Google Scholar]
  21. Castren E, Voikar V, Rantamaki T, 2007. Role of neurotrophic factors in depression. Curr Opin Pharmacol 7, 18–21. [DOI] [PubMed] [Google Scholar]
  22. Challet E, 2007. Minireview: Entrainment of the suprachiasmatic clockwork in diurnal and nocturnal mammals. Endocrinology 148, 5648–5655. [DOI] [PubMed] [Google Scholar]
  23. Daan S, Aschoff J, 2001. The entrainment of circadian systems, Circadian Clocks. Springer, pp. 7–43. [Google Scholar]
  24. Deats SP, Adidharma W, Lonstein JS, Yan L, 2014. Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency. Neuroscience 272C, 252–260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Deurveilher S, Semba K, 2005. Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: implications for the circadian control of behavioural state. Neuroscience 130, 165–183. [DOI] [PubMed] [Google Scholar]
  26. Donlin M, Cavanaugh BL, Spagnuolo OS, Yan L, Lonstein JS, 2014. Effects of sex and reproductive experience on the number of orexin A-immunoreactive cells in the prairie vole brain. Peptides 57, 122–128. [DOI] [PubMed] [Google Scholar]
  27. Duman RS, 2002. Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry 17 Suppl 3, 306–310. [DOI] [PubMed] [Google Scholar]
  28. Einat H, Kronfeld-Schor N, Eilam D, 2006. Sand rats see the light: short photoperiod induces a depression-like response in a diurnal rodent. Behav Brain Res 173, 153–157. [DOI] [PubMed] [Google Scholar]
  29. Evans JA, Davidson AJ, 2013. Health consequences of circadian disruption in humans and animal models. Prog Mol Biol Transl Sci 119, 283–323. [DOI] [PubMed] [Google Scholar]
  30. Even C, Schroder CM, Friedman S, Rouillon F, 2008. Efficacy of light therapy in nonseasonal depression: a systematic review. J Affect Disord 108, 11–23. [DOI] [PubMed] [Google Scholar]
  31. Fite KV, Janusonis S, 2001. Retinal projection to the dorsal raphe nucleus in the Chilean degus (Octodon degus). Brain Res 895, 139–145. [DOI] [PubMed] [Google Scholar]
  32. Fite KV, Janusonis S, Foote W, Bengston L, 1999. Retinal afferents to the dorsal raphe nucleus in rats and Mongolian gerbils. J Comp Neurol 414, 469–484. [DOI] [PubMed] [Google Scholar]
  33. Forbes D, Culum I, Lischka AR, Morgan DG, Peacock S, Forbes J, Forbes S, 2009. Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia. Cochrane Database Syst Rev, CD003946. [DOI] [PubMed] [Google Scholar]
  34. Fortuyn HA, Lappenschaar MA, Furer JW, Hodiamont PP, Rijnders CA, Renier WO, Buitelaar JK, Overeem S, 2010. Anxiety and mood disorders in narcolepsy: a case-control study. Gen Hosp Psychiatry 32, 49–56. [DOI] [PubMed] [Google Scholar]
  35. Foster RG, Hankins MW, 2002. Non-rod, non-cone photoreception in the vertebrates. Prog Retin Eye Res 21, 507–527. [DOI] [PubMed] [Google Scholar]
  36. Frazao R, Pinato L, da Silva AV, Britto LR, Oliveira JA, Nogueira MI, 2008. Evidence of reciprocal connections between the dorsal raphe nucleus and the retina in the monkey Cebus apella. Neurosci Lett 430, 119–123. [DOI] [PubMed] [Google Scholar]
  37. Fu Y, Liao HW, Do MT, Yau KW, 2005. Non-image-forming ocular photoreception in vertebrates. Curr Opin Neurobiol 15, 415–422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Gaillard F, Karten HJ, Sauve Y, 2013. Retinorecipient areas in the diurnal murine rodent Arvicanthis niloticus: a disproportionally large superior colliculus. J Comp Neurol 521, 16991726. [DOI] [PubMed] [Google Scholar]
  39. Gbyl K, Ostergaard Madsen H, Dunker Svendsen S, Petersen PM, Hageman I, Volf C, Martiny K, 2016. Depressed Patients Hospitalized in Southeast-Facing Rooms Are Discharged Earlier than Patients in Northwest-Facing Rooms. Neuropsychobiology 74, 193–201. [DOI] [PubMed] [Google Scholar]
  40. Gerashchenko D, Shiromani PJ, 2004. Different neuronal phenotypes in the lateral hypothalamus and their role in sleep and wakefulness. Mol Neurobiol 29, 41–59. [DOI] [PubMed] [Google Scholar]
  41. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, Wisner KL, Nemeroff CB, 2005. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 162, 656–662. [DOI] [PubMed] [Google Scholar]
  42. Hastings MH, Reddy AB, Maywood ES, 2003. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 4, 649–661. [DOI] [PubMed] [Google Scholar]
  43. Hattar S, Kumar M, Park A, Tong P, Tung J, Yau KW, Berson DM, 2006. Central projections of melanopsin-expressing retinal ganglion cells in the mouse. J Comp Neurol 497, 326–349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Hattar S, Lucas RJ, Mrosovsky N, Thompson S, Douglas RH, Hankins MW, Lem J, Biel M, Hofmann F, Foster RG, Yau KW, 2003. Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. Nature 424, 76–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Hebert M, Dumont M, Paquet J, 1998. Seasonal and diurnal patterns of human illumination under natural conditions. Chronobiol Int 15, 59–70. [DOI] [PubMed] [Google Scholar]
  46. Heschong L, 2002. Daylighting makes a difference. Educational Facility Planner 37, 5–14. [Google Scholar]
  47. Heschong L, Wright R, Okura S, Klein P, Simner M, Berman S, Clear R, 2002. Daylighting impacts on human performance in school. Journal of Illuminating Engineering Society 31, 101–114. [Google Scholar]
  48. Howland RH, 2009. An overview of seasonal affective disorder and its treatment options. Phys Sportsmed 37, 104–115. [DOI] [PubMed] [Google Scholar]
  49. Ikeno T, Deats SP, Soler J, Lonstein JS, Yan L, 2016. Decreased daytime illumination leads to anxiety-like behaviors and HPA axis dysregulation in the diurnal grass rat (Arvicanthis niloticus). Behav Brain Res 300, 77–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Ikeno T, Yan L, 2018. A comparison of the orexin receptor distribution in the brain between diurnal Nile grass rats (Arvicanthis niloticus) and nocturnal mice (Mus musculus). Brain Res 1690, 89–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Itzhacki J, Clesse D, Goumon Y, Van Someren EJ, Mendoza J, 2018. Light rescues circadian behavior and brain dopamine abnormalities in diurnal rodents exposed to a winter-like photoperiod. Brain Struct Funct 223, 2641–2652. [DOI] [PubMed] [Google Scholar]
  52. Jaeger LB, Farr SA, Banks WA, Morley JE, 2002. Effects of orexin-A on memory processing. Peptides 23, 1683–1688. [DOI] [PubMed] [Google Scholar]
  53. Jarrard LE, 1993. On the role of the hippocampus in learning and memory in the rat. Behav Neural Biol 60, 9–26. [DOI] [PubMed] [Google Scholar]
  54. Johnson PL, Truitt W, Fitz SD, Minick PE, Dietrich A, Sanghani S, Traskman-Bendz L, Goddard AW, Brundin L, Shekhar A, 2010. A key role for orexin in panic anxiety. Nat Med 16, 111–115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Johnson RF, Morin LP, Moore RY, 1988. Retinohypothalamic projections in the hamster and rat demonstrated using cholera toxin. Brain Res 462, 301–312. [DOI] [PubMed] [Google Scholar]
  56. Jung CM, Khalsa SB, Scheer FA, Cajochen C, Lockley SW, Czeisler CA, Wright KP Jr., 2010. Acute effects of bright light exposure on cortisol levels. J Biol Rhythms 25, 208–216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Kulikov AV, Popova NK, 2015. Tryptophan hydroxylase 2 in seasonal affective disorder: underestimated perspectives? Rev Neurosci. [DOI] [PubMed] [Google Scholar]
  58. Lam RW, Levitt AJ, Levitan RD, Enns MW, Morehouse R, Michalak EE, Tam EM, 2006. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry 163, 805–812. [DOI] [PubMed] [Google Scholar]
  59. Lam RW, Tam EM, Grewal A, Yatham LN, 2001. Effects of alpha-methyl-para-tyrosineinduced catecholamine depletion in patients with seasonal affective disorder in summer remission. Neuropsychopharmacology 25, S97–101. [DOI] [PubMed] [Google Scholar]
  60. Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD, 2002. Effect of sunlight and season on serotonin turnover in the brain. Lancet 360, 1840–1842. [DOI] [PubMed] [Google Scholar]
  61. Lance SJ, Miller SC, Holtsclaw LI, Turner BB, 1998. Photoperiod regulation of mineralocorticoid receptor mRNA expression in hamster hippocampus. Brain Res 780, 342–347. [DOI] [PubMed] [Google Scholar]
  62. Leach G, Adidharma W, Yan L, 2013 -a. Depression-like responses induced by daytime light deficiency in the diurnal grass rat (Arvicanthis niloticus). PLoS One 8, e57115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Leach G, Ramanathan C, Langel J, Yan L, 2013. Responses of brain and behavior to changing day-length in the diurnal grass rat (Arvicanthis niloticus). Neuroscience 234, 31–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Leach G, Ramanathan C, Langel J, Yan L, 2013 -b. Responses of brain and behavior to changing day-length in the diurnal grass rat (Arvicanthis niloticus). Neuroscience 234C, 31–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Leak RK, Moore RY, 1997. Identification of retinal ganglion cells projecting to the lateral hypothalamic area of the rat. Brain Res 770, 105–114. [DOI] [PubMed] [Google Scholar]
  66. Lee YA, Hyun KJ, Sone Y, Tokura H, 2001. Effects of bright or dim light during the daytime on digestive activity in humans. Naturwissenschaften 88, 126–128. [DOI] [PubMed] [Google Scholar]
  67. Levitan RD, 2007. The chronobiology and neurobiology of winter seasonal affective disorder. Dialogues Clin Neurosci 9, 315–324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Lewy AJ, 2009. Circadian misalignment in mood disturbances. Curr Psychiatry Rep 11, 459–465. [DOI] [PubMed] [Google Scholar]
  69. Lewy AJ, Rough JN, Songer JB, Mishra N, Yuhas K, Emens JS, 2007. The phase shift hypothesis for the circadian component of winter depression. Dialogues Clin Neurosci 9, 291–300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Luykx JJ, Bakker SC, van Geloven N, Eijkemans MJ, Horvath S, Lentjes E, Boks MP, Strengman E, DeYoung J, Buizer-Voskamp JE, Cantor RM, Lu A, van Dongen EP, Borgdorff P, Bruins P, Kahn RS, Ophoff RA, 2013. Seasonal variation of serotonin turnover in human cerebrospinal fluid, depressive symptoms and the role of the 5-HTTLPR. Transl Psychiatry 3, e311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. MacQueen G, Frodl T, 2011. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry 16, 252–264. [DOI] [PubMed] [Google Scholar]
  72. Major DE, Rodman HR, Libedinsky C, Karten HJ, 2003. Pattern of retinal projections in the California ground squirrel (Spermophilus beecheyi): anterograde tracing study using cholera toxin. J Comp Neurol 463, 317–340. [DOI] [PubMed] [Google Scholar]
  73. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK, 2001. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435, 6–25. [DOI] [PubMed] [Google Scholar]
  74. Marston OJ, Williams RH, Canal MM, Samuels RE, Upton N, Piggins HD, 2008. Circadian and dark-pulse activation of orexin/hypocretin neurons. Mol Brain 1, 19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Matheson GJ, Schain M, Almeida R, Lundberg J, Cselenyi Z, Borg J, Varrone A, Farde L, Cervenka S, 2015. Diurnal and seasonal variation of the brain serotonin system in healthy male subjects. Neuroimage 112, 225–231. [DOI] [PubMed] [Google Scholar]
  76. Matsuzaki M, Honkura N, Ellis-Davies GC, Kasai H, 2004. Structural basis of long-term potentiation in single dendritic spines. Nature 429, 761–766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. McClung CA, 2011. Circadian rhythms and mood regulation: insights from pre-clinical models. Eur Neuropsychopharmacol 21 Suppl 4, S683–693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Mendoza J, Clesse D, Pevet P, Challet E, 2010. Food-reward signalling in the suprachiasmatic clock. J Neurochem 112, 1489–1499. [DOI] [PubMed] [Google Scholar]
  79. Meyer C, Muto V, Jaspar M, Kusse C, Lambot E, Chellappa SL, Degueldre C, Balteau E, Luxen A, Middleton B, Archer SN, Collette F, Dijk DJ, Phillips C, Maquet P, Vandewalle G, 2016. Seasonality in human cognitive brain responses. Proc Natl Acad Sci U S A 113, 3066–3071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Mills P, Tomkins S, Schlangen L, 2007. The effect of high correlated colour temperature office lighting on employee wellbeing and work performance. J Circadian Rhythms 5, 2–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Minors DS, Waterhouse JM, Wirz-Justice A, 1991. A human phase-response curve to light. Neurosci Lett 133, 36–40. [DOI] [PubMed] [Google Scholar]
  82. Morin LP, Studholme KM, 2014. Retinofugal projections in the mouse. J Comp Neurol 522, 3733–3753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Mott M, Robinson D, Walden A, Bernette J, Rutherford A, 2012. Illuminating the Effects of Dynamic Lighting on Student Learning. Sage Open, 1–9. [Google Scholar]
  84. Neumeister A, Konstantinidis A, Praschak-Rieder N, Willeit M, Hilger E, Stastny J, Kasper S, 2001. Monoaminergic function in the pathogenesis of seasonal affective disorder. Int J Neuropsychopharmacol 4, 409–420. [DOI] [PubMed] [Google Scholar]
  85. Nixon JP, Smale L, 2007. A comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and diurnal rodents. Behav Brain Funct 3, 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Nocjar C, Zhang J, Feng P, Panksepp J, 2012. The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system, and of dynorphin and orexin in the hypothalamus. Neuroscience 218, 138–153. [DOI] [PubMed] [Google Scholar]
  87. Nussbaumer B, Kaminski-Hartenthaler A, Forneris CA, Morgan LC, Sonis JH, Gaynes BN, Greenblatt A, Wipplinger J, Lux LJ, Winkler D, Van Noord MG, Hofmann J, Gartlehner G, 2015. Light therapy for preventing seasonal affective disorder. Cochrane Database Syst Rev, CD011269. [DOI] [PubMed] [Google Scholar]
  88. O’Brien JT, Sahakian BJ, Checkley SA, 1993. Cognitive impairments in patients with seasonal affective disorder. Br J Psychiatry 163, 338–343. [DOI] [PubMed] [Google Scholar]
  89. Ohayon MM, 2013. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med 14, 488–492. [DOI] [PubMed] [Google Scholar]
  90. Pariante CM, Lightman SL, 2008. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31, 464–468. [DOI] [PubMed] [Google Scholar]
  91. Park S-J, Tokura H, 1999. Bright light exposure during the daytime affects circadian rhythms of urinary melatonin and salivary immunoglobulin A. Chronobiology international 16, 359–371. [DOI] [PubMed] [Google Scholar]
  92. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS, 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18, 9996–10015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Praschak-Rieder N, Willeit M, Wilson AA, Houle S, Meyer JH, 2008. Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry 65, 1072–1078. [DOI] [PubMed] [Google Scholar]
  94. Prendergast BJ, Kay LM, 2008. Affective and adrenocorticotrophic responses to photoperiod in Wistar rats. J Neuroendocrinol 20, 261–267. [DOI] [PubMed] [Google Scholar]
  95. Prendergast BJ, Nelson RJ, 2005. Affective responses to changes in day length in Siberian hamsters (Phodopus sungorus). Psychoneuroendocrinology 30, 438–452. [DOI] [PubMed] [Google Scholar]
  96. Pyter LM, Adelson JD, Nelson RJ, 2007. Short days increase hypothalamic-pituitaryadrenal axis responsiveness. Endocrinology 148, 3402–3409. [DOI] [PubMed] [Google Scholar]
  97. Pyter LM, Reader BF, Nelson RJ, 2005. Short photoperiods impair spatial learning and alter hippocampal dendritic morphology in adult male white-footed mice (Peromyscus leucopus). J Neurosci 25, 4521–4526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Redlin U, 2001. Neural basis and biological function of masking by light in mammals: suppression of melatonin and locomotor activity. Chronobiol Int 18, 737–758. [DOI] [PubMed] [Google Scholar]
  99. Refinetti R, 2008. The diversity of temporal niches in mammals. Biological Rhythm Research 39, 173–192. [Google Scholar]
  100. Ren C, Luan L, Wui-Man Lau B, Huang X, Yang J, Zhou Y, Wu X, Gao J, Pickard GE, So KF, Pu M, 2013. Direct retino-raphe projection alters serotonergic tone and affective behavior. Neuropsychopharmacology 38, 1163–1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Reuss S, Fuchs E, 2000. Anterograde tracing of retinal afferents to the tree shrew hypothalamus and raphe. Brain Res 874, 66–74. [DOI] [PubMed] [Google Scholar]
  102. Ribeiro MV, Hasten-Reiter Junior HN, Ribeiro EA, Juca MJ, Barbosa FT, SousaRodrigues CF, 2015. Association between visual impairment and depression in the elderly: a systematic review. Arq Bras Oftalmol 78, 197–201. [DOI] [PubMed] [Google Scholar]
  103. Riemersma-van der Lek RF, Swaab DF, Twisk J, Hol EM, Hoogendijk WJ, Van Someren EJ, 2008. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA 299, 2642–2655. [DOI] [PubMed] [Google Scholar]
  104. Roecklein KA, Rohan KJ, Duncan WC, Rollag MD, Rosenthal NE, Lipsky RH, Provencio I, 2009. A missense variant (P10L) of the melanopsin (OPN4) gene in seasonal affective disorder. J Affect Disord 114, 279–285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA, 1984. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 41, 72–80. [DOI] [PubMed] [Google Scholar]
  106. Rotter A, Asemann R, Decker A, Kornhuber J, Biermann T, 2011. Orexin expression and promoter-methylation in peripheral blood of patients suffering from major depressive disorder. J Affect Disord 131, 186–192. [DOI] [PubMed] [Google Scholar]
  107. Ruger M, Gordijn MC, Beersma DG, de Vries B, Daan S, 2006. Time-of-day-dependent effects of bright light exposure on human psychophysiology: comparison of daytime and nighttime exposure. Am J Physiol Regul Integr Comp Physiol 290, R1413–1420. [DOI] [PubMed] [Google Scholar]
  108. Sakurai T, 2005. Orexin and orexin receptors, Hypocretins. Springer, pp. 13–23. [Google Scholar]
  109. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M, 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573–585. [DOI] [PubMed] [Google Scholar]
  110. Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauss M, Baum P, Hegerl U, Schonknecht P, 2011. CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Res 190, 240–243. [DOI] [PubMed] [Google Scholar]
  111. Schwartz MD, Urbanski HF, Nunez AA, Smale L, 2011. Projections of the suprachiasmatic nucleus and ventral subparaventricular zone in the Nile grass rat (Arvicanthis niloticus). Brain Res 1367, 146–161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Shen H, Semba K, 1994. A direct retinal projection to the dorsal raphe nucleus in the rat. Brain Res 635, 159–168. [DOI] [PubMed] [Google Scholar]
  113. Shin LM, Liberzon I, 2010. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35, 169–191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Sil’kis I, 2013. Possible Mechanisms for the Effects of Orexin on Hippocampal Functioning and Spatial Learning (analytical review). Neuroscience and Behavioral Physiology 43, 1049–1057. [Google Scholar]
  115. Smale L, Lee T, Nunez AA, 2003. Mammalian diurnality: some facts and gaps. J Biol Rhythms 18, 356–366. [DOI] [PubMed] [Google Scholar]
  116. Soffin EM, Gill CH, Brough SJ, Jerman JC, Davies CH, 2004. Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus. Neuropharmacology 46, 1168–1176. [DOI] [PubMed] [Google Scholar]
  117. Soler JE, Robison AJ, Nunez AA, Yan L, 2018. Light modulates hippocampal function and spatial learning in a diurnal rodent species: A study using male nile grass rat (Arvicanthis niloticus). Hippocampus 28, 189–200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Sone Y, Hyun K-J, Nishimura S, Lee Y-A, Tokura H, 2003. Effects of dim or bright-light exposure during the daytime on human gastrointestinal activity. Chronobiology international 20, 123–133. [DOI] [PubMed] [Google Scholar]
  119. Song J, Kim E, Kim CH, Song HT, Lee JE, 2015. The role of orexin in post-stroke inflammation, cognitive decline, and depression. Mol Brain 8, 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Squire LR, 1992. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 99, 195–231. [DOI] [PubMed] [Google Scholar]
  121. Steinman MQ, Crean KK, Trainor BC, 2011. Photoperiod interacts with food restriction in performance in the Barnes maze in female California mice. Eur J Neurosci 33, 361–370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Sullivan B, Payne TW, 2007. Affective disorders and cognitive failures: a comparison of seasonal and nonseasonal depression. Am J Psychiatry 164, 1663–1667. [DOI] [PubMed] [Google Scholar]
  123. Tang YP, Stumpfig M, Samad F, Xiong H, Linning-Duffy K, Lonstein JS, Yan L, 2018. Sex differences in Effects of Light Intensity on Orexinergic System in the Diurnal Nile Grass Rat (Arvicanthis niloticus) International Congress of Neuroendocrionology, 22nd Annual Meeting of the Soceity for Behavioral Neuroendocrinology, Toronto, Canada. [Google Scholar]
  124. Tao R, Ma Z, McKenna JT, Thakkar MM, Winston S, Strecker RE, McCarley RW, 2006. Differential effect of orexins (hypocretins) on serotonin release in the dorsal and median raphe nuclei of freely behaving rats. Neuroscience 141, 1101–1105. [DOI] [PubMed] [Google Scholar]
  125. Terman M, Amira L, Terman JS, Ross DC, 1996. Predictors of response and nonresponse to light treatment for winter depression. Am J Psychiatry 153, 1423–1429. [DOI] [PubMed] [Google Scholar]
  126. Terman M, Terman JS, 2005. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr 10, 647–663; quiz 672. [DOI] [PubMed] [Google Scholar]
  127. Thannickal TC, Nienhuis R, Siegel JM, 2009. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep 32, 993–998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM, 1998. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438, 71–75. [DOI] [PubMed] [Google Scholar]
  129. Tsien JZ, Huerta PT, Tonegawa S, 1996. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87, 1327–1338. [DOI] [PubMed] [Google Scholar]
  130. Tsujino N, Sakurai T, 2009. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 61, 162–176. [DOI] [PubMed] [Google Scholar]
  131. Turner PL, Van Someren EJ, Mainster MA, 2010. The role of environmental light in sleep and health: effects of ocular aging and cataract surgery. Sleep Med Rev 14, 269–280. [DOI] [PubMed] [Google Scholar]
  132. Tuunainen A, Kripke DF, Endo T, 2004. Light therapy for non-seasonal depression. Cochrane Database Syst Rev, CD004050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Viola AU, James LM, Schlangen LJ, Dijk DJ, 2008. Blue-enriched white light in the workplace improves self-reported alertness, performance and sleep quality. Scand J Work Environ Health 34, 297–306. [DOI] [PubMed] [Google Scholar]
  134. Walch JM, Rabin BS, Day R, Williams JN, Choi K, Kang JD, 2005. The effect of sunlight on postoperative analgesic medication use: a prospective study of patients undergoing spinal surgery. Psychosom Med 67, 156–163. [DOI] [PubMed] [Google Scholar]
  135. Wennstrom M, Londos E, Minthon L, Nielsen HM, 2012. Altered CSF orexin and alphasynuclein levels in dementia patients. J Alzheimers Dis 29, 125–132. [DOI] [PubMed] [Google Scholar]
  136. Wright KP, Lowry CA, Lebourgeois MK, 2012. Circadian and wakefulness-sleep modulation of cognition in humans. Front Mol Neurosci 5, 50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Yamadera H, Ito T, Suzuki H, Asayama K, Ito R, Endo S, 2000. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin Neurosci 54, 352–353. [DOI] [PubMed] [Google Scholar]
  138. Yan L, Smale L, Nunez AA, 2018. Circadian and photic modulation of daily rhythms in diurnal mammals. Eur J Neurosci in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Yan L, Soler J, Russell V, Nunez AA, 2017. Sex Differences in the Photic Modulation of Spatial Learning and Hippocampal Plasticity in the Diurnal Grass Rat (Arvicanthis niloticus), 21st Annual Meeting of the Society for Behavioral Neuoendocrinology, Long Beach, CA. [Google Scholar]
  140. Zeitzer JM, Dijk DJ, Kronauer R, Brown E, Czeisler C, 2000. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 526 Pt 3, 695–702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Zhao X, Zhang R, Tang S, Ren Y, Yang W, Liu X, Tang J, 2014. Orexin-A-induced ERK1/2 activation reverses impaired spatial learning and memory in pentylenetetrazol-kindled rats via OX1R-mediated hippocampal neurogenesis. Peptides 54, 140–147. [DOI] [PubMed] [Google Scholar]
  142. Zorn JV, Schur RR, Boks MP, Kahn RS, Joels M, Vinkers CH, 2017. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology 77, 25–36. [DOI] [PubMed] [Google Scholar]

RESOURCES